Johnson & Johnson Stock News

John C. Reed, Executive Vice President, Innovative Medicine and R&D of Johnson & Johnson (JNJ 0.35%) , executed an open market sale of 19,137 shares as disclosed in a Form 4 filed July 18, 2025.

Right now is not a good time in the healthcare sector. Various companies across the space are well below highs while the broader stock market chugs along at all-time highs.

Companies that are increasing their dividends are good bets to hold their own during the next economic downturn.

Long-term dividend plays tend to be more stable than many other stocks—after all, this stability is why they are able to provide consistent dividends in the first place. Traditional dividend stocks are large, well-established companies that are unlikely to experience significant volatility apart from trends affecting the broader market.

Investors have checked plenty of boxes off their 2021 market bingo cards lately: a V-shaped recovery in the S&P 500 after a quick bear market, a wild cryptocurrency rally, and beaten-down meme stocks generating short squeezes.

Dividend stocks can be great long-term investments. Many top dividend payers have long histories of increasing their payouts and delivering above-average total returns.

Priorities change as you enter new seasons of life. That's especially true for your retirement years.

Verizon is the only Dow stock currently meeting the 'dogcatcher' ideal: annual dividends from $1K invested exceed its share price and are supported by free cash flow. Analyst forecasts suggest top Dow dividend stocks could deliver 14.93% to 41.48% net gains by August 2026, with an average estimated gain of 23.33%. Most Dow stocks remain overpriced relative to their dividends, but market pullbac...